Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | PRKACA | P17612 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | ADK | P55263 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL989535 | 0.79 | CYP2A6 (0.52) | RAB9AHSP90AA1ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL3597375 | 0.78 | RAB9A (0.41) | KMT2ARAB9AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL16720064 | 0.77 | KMO (0.45) | KMT2AMEN1PRKACANOTUMALDH1A1 | |
| SCHEMBL3654046 | 0.77 | CYP1A2 (0.47) | KMT2ARAB9AMEN1ALDH1A1HPGD | |
| SCHEMBL15477525 | 0.77 | KMO (0.45) | RAB9ANOTUMSMN1; SMN2IDO1NPC1 | |
| SCHEMBL11107619 | 0.77 | METAP2 (0.45) | METAP2KEAP1 | |
| SCHEMBL16720101 | 0.77 | HSD17B1 (0.52) | METAP2 | |
| SCHEMBL2909003 | 0.75 | MEN1 (0.52) | KMT2ARAB9AMEN1ADORA2AALDH1A1 | |
| SCHEMBL558888 | 0.74 | KDM4E (0.58) | RAB9AHSP90AA1ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL990825 | 0.74 | CYP2A6 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290273-A | Fluorenyl deuterated amino compound and organic light-emitting device | 南京高光半导体材料有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118184522-A | Amino compound with deuterated fluorenyl and organic light-emitting device | 南京高光半导体材料有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2024119977-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DIODE DEVICE COMPRISING SAME | 四川阿格瑞新材料有限公司 | 2024-06-13 | — | — | WO | claimed |
| US-11987588-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2024-05-21 | — | — | US | claimed |
| CN-117964501-A | Spirobifluorenylamino compound and organic electroluminescent device | 南京高光半导体材料有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117964500-A | Amino compound with spirobifluorene group and organic electroluminescent device | 南京高光半导体材料有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117946044-A | Amino compound with benzophenanthrene furan group and organic light-emitting device | 南京高光半导体材料有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117720584-A | Cyclometallated iridium (III) complex, preparation method and application thereof as photosensitizer | 中国科学院深圳先进技术研究院 | 2024-03-19 | — | — | CN | claimed |
| CN-117682998-A | Electron transport material, preparation method thereof and light-emitting device | 吉林奥来德光电材料股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| US-20240025884-A1 | COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | DONG-A ST CO., LTD. (KR) | 2024-01-25 | — | — | US | claimed |
| WO-1999025789-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL SHUTTER | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1999-05-27 | — | — | WO | claimed |
| EP-0903391-A1 | \"Liquid crystal composition and liquid crystal shutter\ | Sharp Kabushiki Kaisha (JP) | 1999-03-24 | — | — | EP | claimed |
| WO-1998047880-A1 | ISOXAZOLE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1998-10-29 | — | — | WO | claimed |
| WO-1998008813-A1 | COMBINATORIAL PROCESS FOR PREPARING SUBSTITUTED PYRROLIDINE LIBRARIES | ELI LILLY AND COMPANY (US) | 1998-03-05 | — | — | WO | claimed |
| EP-0821670-A1 | N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS | Novartis AG (CH) | 1998-02-04 | — | — | EP | claimed |
| US-5654326-A | SEPTIC SHOCK; HUMAN NONPANCREATIC SECRETORY PHOSPHOLIPASE | ELI LILLY AND COMPANY (US) | 1997-08-05 | — | — | US | claimed |
| US-5641800-A | ALLEVIATE EFFECT OF SEPTIC SHOCK, ADULT RESPIRATORY DISTRESS SYNDROME, PANCREATITIS, TRAUMA, BRONCHIAL ASTHMA, ALLERGIC RHINITIS, AND RHEUMATOID ARTHRITIS | ELI LILLY AND COMPANY (US) | 1997-06-24 | — | — | US | claimed |
| WO-1996033170-A1 | N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS | NOVARITS AG (CH) | 1996-10-24 | — | — | WO | claimed |
| US-4659736-A | Benzoyl urea compounds as agents for repelling snails and slugs | BAYER AKTIENGESELLSCHAFT (DE) | 1987-04-21 | — | — | US | claimed |
| EP-0150031-A2 | Agent for combatting slugs and snails | BAYER AG (DE) | 1985-07-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11987588-B2 | Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto | ADRB3, ADRB1, ADRB2 | KMT2A 4684/4885RAB9A 2400/4885MEN1 4306/4885 |
| US-20240025884-A1 | COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | EIF2AK4, GCN1, GCGR | KMT2A 4282/4885RAB9A 1472/4885MEN1 1984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.